Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective.
Radiology. 2019 Feb;290(2):278-287. doi: 10.1148/radiol.2018180212. Epub 2019 Jan 8.
Wang GX1, Baggett TP1, Pandharipande PV1, Park ER1, Percac-Lima S1, Shepard JO1, Fintelmann FJ1, Flores EJ1.
Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer screening (LCS) with low-dose CT reduces mortality among high-risk current and former smokers and has been covered by public and private insurers without cost sharing since 2015. Patients and referring providers confront numerous barriers to participation in screening. To best serve in multidisciplinary efforts to expand LCS nationwide, radiologists must be knowledgeable of these challenges. A better understanding of the difficulties confronted by other stakeholders will help radiologists continue to collaboratively guide the growth of LCS programs in their communities. This article reviews barriers to participation in LCS for patients and referring providers, as well as possible solutions and interventions currently underway.